EMA recommends eight drugs for approval from April meeting
The EMA's human medicines committee has adopted a positive opinion for eight medicines, recommending their marketing authorisation.
List view / Grid view
The EMA's human medicines committee has adopted a positive opinion for eight medicines, recommending their marketing authorisation.
Cablivi and Egaten were the two top novel drugs approved last month, with a focus on parasitic infestation and the rare disorder, aTTP...